Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Single-Blind, Controlled Trial of Topical Raplixa™ (Fibrin Sealant [Human]) in Intraoperative Surgical Hemostasis in a Pediatric Population
Conditions
Interventions
Raplixa
Gelfoam
+1 more
Locations
13
United States
Arizona Burn Center at Maricopa Medical Center
Phoenix, Arizona, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
Shriners Hospital for Children
Sacramento, California, United States
Nemours Children's Specialty Care
Jacksonville, Florida, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Ann and Robert H Lurie Childrens Hospital of Chicago
Chicago, Illinois, United States
Start Date
December 4, 2014
Primary Completion Date
November 17, 2017
Completion Date
March 6, 2018
Last Updated
February 5, 2020
NCT01653769
NCT02284256
NCT01731938
NCT01754480
NCT02159105
Lead Sponsor
Mallinckrodt
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions